Basic Health International (BHI) envisions a world where no woman dies from cervical cancer. While largely preventable in the United States, cervical cancer remains a leading cause of cancer death in many countries around the world, with 90% of the mortality disproportionately affecting women in low- and middle-income countries. Through cutting-edge research, early prevention and novel treatment methods, BHI aims to change this harsh reality.
Thus far, BHI has screened and/or treated more than 50,000 women and trained over 1,500 healthcare providers. The organization has expanded its focus to include designing and implementing cutting-edge research that allows innovative science to help some of the most vulnerable women in the world. Projects have focused on the development of low-cost screening and treatment alternatives for cervical precancer that can reach patients in isolated and/or resource-poor environments. Currently, BHI is operating clinical trials in Latin America and the Caribbean and hopes that their research will result in a world where no woman dies of cervical cancer, an entirely preventable disease.